PAPD7 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.47129999961138E-07 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.86309999999202E-05 |
Normal-vs-Stage2 |
1.446010E-02 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.244200E-03 |
Stage1-vs-Stage2 |
2.939400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.339800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.199200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.37169999994791E-06 |
Normal-vs-AfricanAmerican |
2.772200E-01 |
Normal-vs-Asian |
1.603210E-04 |
Caucasian-vs-AfricanAmerican |
1.063790E-01 |
Caucasian-vs-Asian |
7.809800E-01 |
AfricanAmerican-vs-Asian |
3.012200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.280500E-03 |
Normal-vs-Female |
3.61579999996753E-06 |
Male-vs-Female |
9.092400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.961500E-03 |
Normal-vs-Extreme_Weight |
7.591500E-04 |
Normal-vs-Obese |
2.26719999996128E-06 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
4.998200E-02 |
Normal_Weight-vs-Obese |
7.647900E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.140600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.646150E-04 |
Normal-vs-Age(41-60Yrs) |
3.682600E-03 |
Normal-vs-Age(61-80Yrs) |
3.00229999972146E-07 |
Normal-vs-Age(81-100Yrs) |
4.051400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.811800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.690800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.449600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.874200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.189400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.333600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.276200E-01 |
Normal-vs-Grade 3 |
4.269000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.969400E-01 |
Grade 2-vs-Grade 4 |
4.276200E-01 |
Grade 3-vs-Grade 4 |
4.269000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.80972999999085E-05 |
Normal-vs-N1 |
2.18110000005378E-06 |
N0-vs-N1 |
9.468600E-01 |
|
|